三諾生物(300298.SZ):仲裁法院裁定NIPRO向Trividia賠償損失1747.75萬美元及利息
格隆匯 10 月 16日丨三諾生物(300298.SZ)公佈,公司參股子公司深圳市心諾健康產業投資有限公司全資子公司Trividia Health Inc. (“Trividia”)於近日收到國際商會國際仲裁法院(ICC INTERNATIONAL COURT OF ARBITRATION)送達的《裁決書》(CASE No. 23464/MK/PDP),Trividia與NIPRO CORPORATION(Japan)就國際銷售協議糾紛一案和其他糾紛已向國際商會國際仲裁法院提起仲裁申請,仲裁地為紐約,國際商會國際仲裁法院已經作出裁決。
近日,國際商會國際仲裁法院作出裁決如下:由於尼普洛集團違反了《國際經銷協議》的承諾購買量的約定,導致了國際經銷協議的提前終止,申請人由於該協議終止而導致的損失,應當向被申請人進行追償;
國際商會國際仲裁法院裁定被申請人NIPRO CORPORATION (Japan)向申請人Trividia Health Inc. (U.S.A.)賠償由於提前終止國際經銷協議而帶來的損失,共計1747.75萬美元,同時應加上2019年3月8日起到本裁決傳達之日止,以Prime Rate加上2%的年化利率計算的利息;除此之外,被申請人還應當補償申請人法律訴訟服務費用共計240萬美元以及仲裁費用5萬美元。此次仲裁裁決是本案仲裁的終局裁決。
Trividia系公司參股子公司深圳市心諾健康產業投資有限公司(公司持有股份39.74%)的全資子公司,此次仲裁結果對公司本期或期後利潤的最終影響將依據仲裁裁決的實際履行及執行情況而定,存在不確定性。此次仲裁結果對公司生產經營不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.